Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2929
Selected: 0
NCT IDTitle
NCT00364793Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
NCT00357721Atazanavir Twice Daily
NCT03146650Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
NCT02983006Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
NCT05236608A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
NCT00804310Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors
NCT07689006Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens
NCT00162097Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment
NCT03409848Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma
NCT04848116Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca
NCT02105636Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
NCT05413044A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
NCT01254864Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
NCT05478499Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
NCT03400332A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
NCT02832167An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread
NCT01281228The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
NCT03038711A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
NCT03374228A Study to Evaluate the Bioavailability of BMS-986205
NCT00337467Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
NCT02534636Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
NCT02534506Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors
NCT01888900New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
NCT05633264A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan
NCT00904176Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
NCT00002274A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine
NCT07655518A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants
NCT07257120KarXT Concentrations in the Breast Milk and Plasma of Lactating Females
NCT00694603Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
NCT02969668Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients
NCT01409174IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
NCT00560391Dasatinib in Combination With Revlimid (and Dexamethasone)
NCT00677313Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
NCT02880020Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
NCT03563950An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants
NCT04090710SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
NCT03161613Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico
NCT00388674Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01691794Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients
NCT03470922A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
NCT01775631Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma
NCT01354431BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
NCT03305445Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
NCT07221877A Study to Evaluate the Effect of KarXT on Urological Safety
NCT01605994Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects
NCT03939702Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants
NCT03366766Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
NCT06449222Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT00326729Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation
NCT02754154Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants